23andMe is going public via a merger with Richard Branson’s blank-check company
Yahoo! Finance
23andMe, a consumer genetics company, is going public via a merger with Richard Branson's special-purpose acquisition corporation, or SPAC, VG Acquisition Corp., in a deal with an enterprise value of about $3.5 billion, the companies said Thursday.
Continue Reading